BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sackoff JE, Torian LV, Frieden TR, Brudney KF, Menzies IB. Purified protein derivative testing and tuberculosis preventive therapy for HIV-infected patients in New York City. AIDS 1998;12:2017-23. [PMID: 9814870 DOI: 10.1097/00002030-199815000-00013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Akolo C, Bada F, Okpokoro E, Nwanne O, Iziduh S, Usoroh E, Ali T, Ibeziako V, Oladimeji O, Odo M. Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons. World J Virology 2015; 4(2): 105-112 [PMID: 25964875 DOI: 10.5501/wjv.v4.i2.105] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
2 Saraceni V, Pacheco AG, Golub JE, Vellozo V, King BS, Cavalcante SC, Eldred L, Chaisson RE, Durovni B. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. Braz J Infect Dis 2011;15:249-52. [PMID: 21670926 DOI: 10.1016/s1413-8670(11)70184-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
3 Diaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P. Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain. BMC Infect Dis 2010;10:267. [PMID: 20840743 DOI: 10.1186/1471-2334-10-267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
4 Caminero JA. ¿Podemos mejorar la prevención de la tuberculosis? Enfermedades Infecciosas y Microbiología Clínica 2010;28:211-214. [DOI: 10.1016/j.eimc.2009.12.004] [Reference Citation Analysis]
5 Díaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P. [Factors related to non-prescription of tuberculin skin testing in a cohort of HIV-infected people]. Enferm Infecc Microbiol Clin 2010;28:215-21. [PMID: 19683364 DOI: 10.1016/j.eimc.2009.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Bortolotti V, Buvé A. Prophylaxis of opportunistic infections in HIV-infected adults in sub-Saharan Africa: opportunities and obstacles. AIDS 2002;16:1309-17. [PMID: 12131207 DOI: 10.1097/00002030-200207050-00002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
7 Acevedo-Garcia D. Zip code-level risk factors for tuberculosis: neighborhood environment and residential segregation in New Jersey, 1985-1992. Am J Public Health 2001;91:734-41. [PMID: 11344881 DOI: 10.2105/ajph.91.5.734] [Cited by in Crossref: 120] [Cited by in F6Publishing: 131] [Article Influence: 5.7] [Reference Citation Analysis]
8 Wortley PM, Metler RP, Hu DJ, Fleming PL. AIDS among Asians and Pacific Islanders in the United States. American Journal of Preventive Medicine 2000;18:208-14. [DOI: 10.1016/s0749-3797(99)00159-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]